Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cord Blood Stem Cells

Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia

Abstract

To augment graft cell dose, we evaluated the safety of the combined transplantation of two partially HLA-matched umbilical cord blood (UCB) units. Five patients with transfusion-dependent thalassemia, median age 11.1 years (range 10–13.1), received 2 UCB units after myeloablative conditioning. Cord blood units were a 4/6-HLA-match or better with the recipient, and contained a minimum combined pre-freeze CD34 cell dose of 3.0 × 105/kg. All patients engrafted at a median of 15 days (range 12–19). Four patients with durable trilineage engraftment showed acute grade I–III GVHD; none developed extensive chronic GVHD until the date of last contact. The median times to red blood cell transfusion independence and platelet engraftment were 32 and 49 days after transplant, respectively. With a median follow-up of 18.5 months (range 11–32), four patients transplanted with UCB from two different partially HLA-matched donors were transfusion-independent. Therefore, transfusion of two partially HLA-matched UCB units is safe, and may overcome the cell-dose barrier that limits the use of UCB in long-term recipients of multiple transfusions for thalassemia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. La Nasa G, Caocci G, Argiolu F, Giardini C, Locatelli F, Vacca A et al. Unrelated donor stem cell transplantation in adult patients with thalassemia. Bone Marrow Transplant 2005; 36: 971–975.

    Article  CAS  PubMed  Google Scholar 

  2. Bosi A, Bartolozzi B, Guidi S . Allogeneic stem cell transplantation. Transplant Proc 2005; 37: 2667–2669.

    Article  CAS  PubMed  Google Scholar 

  3. Fleischhauer K, Locatelli F, Zecca M, Orofino MG, Giardini C, De Stefano P et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood 2006; 107: 2984–2992.

    Article  CAS  PubMed  Google Scholar 

  4. Hongeng S, Pakakasama S, Chaisiripoomkere W, Chuansumrit A, Sirachainan N, Ungkanont A et al. Outcome of transplantation with unrelated donor bone marrow in children with severe thalassemia. Bone Marrow Transplant 2004; 33: 377–379.

    Article  CAS  PubMed  Google Scholar 

  5. Wagner JE, Barker JN, DeFor TE, Barker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  6. Benito AI, Diaz MA, Gonzalez-Vicent M, Sevilla J, Madero L . Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 2004; 33: 675–690.

    Article  CAS  PubMed  Google Scholar 

  7. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.

    Article  CAS  PubMed  Google Scholar 

  8. Goldstein G, Toren A, Nagler A . Human umbilical cord blood biology, transplantation and plasticity. Curr Med Chem 2006; 13: 1249–1259.

    Article  CAS  PubMed  Google Scholar 

  9. Majhail NS, Brunstein CG, Wagner JE . Double umbilical cord blood transplantation. Curr Opin Immunol 2006; 18: 571–575.

    Article  CAS  PubMed  Google Scholar 

  10. Moroff G, Eichler H, Brand A, Kekomaki R, Kurtz J, Letowska M et al. Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion 2006; 46: 498–500.

    Article  Google Scholar 

  11. Grewal SS, Barker JN, Davies SM, Wagner JE . Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003; 101: 4233–4244.

    Article  CAS  PubMed  Google Scholar 

  12. Tse W, Laughlin MJ . Umbilical cord blood transplantation: a new alternative option. Hematology (Am Soc Hematol Educ Program) 2005, 377–383.

    Article  Google Scholar 

  13. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S et al. Related umbilical cord blood transplantation in thalassemia and sickle cell anemia. Blood 2003; 101: 2137–2143.

    Article  CAS  PubMed  Google Scholar 

  14. Goussetis E, Peristeri J, Kitra V, Kattamis A, Petropoulos D, Papassotiriou I et al. Combined Cord-Blood and Bone Marrow Transplantation for Beta-Thalassemia. Pediatr Hematol Oncol 2000; 17: 307–314.

    Article  CAS  PubMed  Google Scholar 

  15. Ho WL, Lin KH, Wang JD, Hwang JS, Chung CW, Lin DT et al. Financial burden of national health insurance for treating patients with transfusion-dependent thalassemia in Taiwan. Bone Marrow Transplant 2006; 37: 569–574.

    Article  PubMed  Google Scholar 

  16. Li CK, Lai DH, Shing MM, Chik KW, Lee V, Yuen PM . Early iron reduction programme for thalassaemia patients after bone marrow transplantation. Bone Marrow Transplant 2000; 25: 653–656.

    Article  CAS  PubMed  Google Scholar 

  17. Bornstein R, Flores AI, Montalbán MA, del Rey MJ, de la Serna J, Gilsanz F . A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients. Stem Cells 2005; 23: 324–334.

    Article  PubMed  Google Scholar 

  18. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P . Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717–2722.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to the patients and their caretakers for participating in the externally audited results. We would like to thank Professor Delon Wu for his continued support of this program. This work was supported in part by grants from Chang Gung Memorial Hospital (CMRP G33020) and National Science Council (95-2314-B-182A-106).

Material contained in this paper has been presented at the following meetings:

1. Jaing TH. Unrelated cord blood transplantation for hemoglobinopathies. 4th Annual International Umbilical Cord Blood Transplantation Symposium; Los Angeles, CA, USA; May 19–20, 2006.

2. Jaing TH, Tan P, Chan LL, Rosenthal J, Wang B, Gjertson D, Petz L, Chow R. Unrelated Cord Blood Transplantation for Hemoglobinopathy. 11th Congress of the Asia Pacific Bone Marrow Transplantation; Nagoya, Japan; October 27–29, 2006.

3. Jaing TH, Tan P, Rosenthal J, Wang B, Gjertson D, Petz L, Chow R. Unrelated Cord Blood Transplantation (CBT) for Thalassemia. 48th American Society of Hematology Annual Meeting, Orlando, FL, USA; December 9–12, 2006.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T-H Jaing.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jaing, TH., Yang, CP., Hung, IJ. et al. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant 40, 307–311 (2007). https://doi.org/10.1038/sj.bmt.1705737

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705737

Keywords

This article is cited by

Search

Quick links